{"id":92,"date":"2015-11-10T19:24:42","date_gmt":"2015-11-10T19:24:42","guid":{"rendered":"http:\/\/labs.icahn.mssm.edu\/aaronsonlab\/?page_id=92"},"modified":"2023-06-20T13:40:58","modified_gmt":"2023-06-20T13:40:58","slug":"publications","status":"publish","type":"page","link":"https:\/\/labs.icahn.mssm.edu\/aaronsonlab\/publications\/","title":{"rendered":"Publications"},"content":{"rendered":"<ul>\n<li>Esposito, D., Pant, I., Shen, Y., Qiao, R.F., Yang X., Bai, Y., Jin, J., Poulikakos, P.I., and <strong>Aaronson, S.A.,<\/strong> ROCK1 mechano-signaling dependency of human malignancies driven by TEAD\/YAP activation. Nature Communications (2022) 13:703 <a href=\"https:\/\/doi.org\/10.1038\/s41467-022-28319-3\">https:\/\/doi.org\/10.1038\/s41467-022-28319-3<\/a><\/li>\n<li>Rogic, A., Pant, I., Grumolato, L., Fernandez-Rodriguez, R., Edwards, A., Das, S., Sun, A. Yao, S., Qiao, R., Jaffer, S., Sachidanandam, R., Akturk, G., Karlic, R., Skobe, M., and <strong>Aaronson, S.A.<\/strong> High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer. Nature Communications 2021. 12:6889\u00a0 <a href=\"https:\/\/doi.org\/10.1038\/s41467-021-27108-8\">https:\/\/doi.org\/10.1038\/s41467-021-27108-8<\/a>.<\/li>\n<li>Adamopoulos, C., Ahmed, T.A., Tucker, M.R., Ung, P.M.U., Xiao, M., Karouia, Z., Amabile, A., Wu, X., <strong>Aaronson, S.A.,<\/strong> Ang, C., Vito, W.R., Brown, B.D., Schlessinger, A., Herlyn, M., Wang, Q., Shaw, D.E., and Poulikakos, P.I. Exploiting allosteric properties of RAF and MEK inhibitors to target therapy-resistant tumors driven by oncogenic BRAF signaling. Cancer Discovery 2021. Published Online First on February 10, 2021 DOI: 10.1158\/2159-8290.CD-20-1351<\/li>\n<li>Wu, X., Yang, X., Xiong, Y., Li, R., Ito, T., Ahmed, T.A. Karoulia, Z., Adamopoulos, C., Wang, H. Wang, L. Xie, L., Liu, J., Ueberheide, B, <strong>Aaronson, S.A.,<\/strong> Xhen, X., Buchanan, S.G., Sellers, W.R., Jin, J. and Poulikakos, P.I. D Distinct CDK6 complexes determine tumor cell response to CDK4\/6 inhibitors and degraders. Nature Cancer 2021 2: 429-443.<\/li>\n<li>Ahmed, T., Adamopoulos, C., Karoulia, Z., Wu, X., Sachidanandam, R., <strong>Aaronson, S.A.,<\/strong> Poulikakos, PI.\u00a0 SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent Tumors.\u00a0 <u>Cell Rep<\/u>. 2019 Jan 2;26(1):65-78. E5.doi:10.1016\/j.celrep.2018.12.03.<\/li>\n<li>Vijayakumar, S., Liu, L., Wen, H-C., Abu, Y, \u00a0Chong, R., Nastri, H., Bornstein, G.G., Pan, Z-Q., and \u00a0<strong>Aaronson, S.A.<\/strong>\u00a0 \u00a0Extracellular LDLR repeats modulate Wnt signaling activity by promoting LRP6 receptor endocytosis mediated by the Itch E3 ubiquitin ligase.\u00a0 \u00a0<u>Genes &amp; Cancer<\/u>, 2017 8(7) 613-624 PMCID:\u00a0\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5620007\/\">PMC5620007<\/a>.<\/li>\n<li>Munoz-Fontela, C. Mandinova, A., <strong>Aaronson, S.A.,<\/strong> Lee, S. W., Emerging roles of p53 and\u00a0 other tunour-suppressor genes in immune regulation <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Emergining+roles+of+p53+and+other+tunour-suppressor+genes+in+immune+regulation\">Nat Rev Immunol.<\/a> 2016 Dec;16(12):741- 750. doi: 10.1038\/nri.2016.99. Epub 2016 Sep 26. <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5325695\/\">PMC5325695<\/a><\/li>\n<li>Guernet A, Mungamuri SK, Cartier D, Sachidanandam R, Jayaprakash A, Adriouch S, Vezain M, Charbonnier F, Rohkin G, Coutant S, Yao S, Ainani H, Alexandre D, Tournier I, Boyer O5, <strong>Aaronson SA<\/strong>, Anouar Y1, Grumolato L. CRISPR-Barcoding for Intratumor Genetic Heterogeneity Modeling and Functional Analysis of Oncogenic Driver Mutations. <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27453044\">Mol Cell.<\/a> 2016 Aug 4;63(3):526-38. doi: .1016\/j.molcel.2016.06.017. Epub 2016 Jul 21 PMCID: PMC5537739<\/li>\n<li>Troilo, A., Benson, EK., Esposito, D, Garibsingh, R-A., Reddy, PK., Mungamuri, SK., <strong>Aaronson, S.A<\/strong>.\u00a0 Angiomotin stabilization by tankyrase inhibitors antagonizes constitutive TEAD-dependent transcription and proliferation of human tumor cells with Hippo pathway core component mutations<strong>. <\/strong><u>Oncotarget <\/u>2016 Apr 29. doi: 10.18632\/oncotarget.9117. [Epub ahead of print] PMID: 27144834<\/li>\n<li>Mungamuri, SK., Quio, R., Yao, S., Manfredi, JJ., Gu, W. and <strong>Aaronson, S.A<\/strong>., USP7 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0enforces heterochromatinization of P53 target promoters by protecting SUV39H1 from MDM2-mediated degradation. <u>Cell Reports<\/u> 2016 Mar 22;14(11);2528-37 Epub 2016 Mar 10 PMCID: PMC4884055<\/li>\n<li>Kracikova, M., Akiri, G, George, A., Sachidanandam, R., and <strong>Aaronson S.A.<\/strong>\u00a0\u00a0 A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis. <u>Cell Death Differ<\/u>. 2013\u00a0 Jan 11. doi: 10.1038\/cdd.2012.155. [Epub ahead of print] PMID: PMC3595483<\/li>\n<li>Mu\u00f1oz-Fontela C1, Pazos M, Delgado I, Murk W, Mungamuri SK, ta, Garc\u00eda-Sastre A, Moran TM, and <strong>Aaronson S.A.<\/strong>\u00a0 p53 serves as a host antiviral factor that enhances innate and adaptive immune responses to influenza A virus. <u>J Immunol.<\/u> 2011 Dec 15; 187;6428-6436. PMID: PMCID3275346<\/li>\n<li>Mungamuri, S.K., Benson, E.K., Wang, S., Gu, W., Lee, S.W, and <strong>Aaronson, S.A.<\/strong>\u00a0 Tumor suppressor p53-mediated heterochromatin reorganization regulates its cell fate decisions. <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed?term=Tumor%20suppressor%20p53-mediated%20heterochromatin%20reorganization%20regulates%20its%20cell%20fate%20decisions.\">Nat Struct Mol Biol.<\/a> 2012 Apr 1. doi: 10.1038\/nsmb.2271. [Epub ahead of print]\u00a0 PMID: 22466965<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Esposito, D., Pant, I., Shen, Y., Qiao, R.F., Yang X., Bai, Y., Jin, J., Poulikakos, P.I., and Aaronson, S.A., ROCK1 mechano-signaling dependency of human malignancies driven by TEAD\/YAP activation. Nature Communications (2022) 13:703 https:\/\/doi.org\/10.1038\/s41467-022-28319-3 Rogic, A., Pant, I., Grumolato, L., Fernandez-Rodriguez, R., Edwards, A., Das, S., Sun, A. Yao, S., Qiao, R., Jaffer, S., Sachidanandam, [&hellip;]<\/p>\n","protected":false},"author":146,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-92","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/labs.icahn.mssm.edu\/aaronsonlab\/wp-json\/wp\/v2\/pages\/92","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/labs.icahn.mssm.edu\/aaronsonlab\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/labs.icahn.mssm.edu\/aaronsonlab\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/labs.icahn.mssm.edu\/aaronsonlab\/wp-json\/wp\/v2\/users\/146"}],"replies":[{"embeddable":true,"href":"https:\/\/labs.icahn.mssm.edu\/aaronsonlab\/wp-json\/wp\/v2\/comments?post=92"}],"version-history":[{"count":5,"href":"https:\/\/labs.icahn.mssm.edu\/aaronsonlab\/wp-json\/wp\/v2\/pages\/92\/revisions"}],"predecessor-version":[{"id":180,"href":"https:\/\/labs.icahn.mssm.edu\/aaronsonlab\/wp-json\/wp\/v2\/pages\/92\/revisions\/180"}],"wp:attachment":[{"href":"https:\/\/labs.icahn.mssm.edu\/aaronsonlab\/wp-json\/wp\/v2\/media?parent=92"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}